Latest Breaking News On - Pradip pathare - Page 1 : comparemela.com

Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry

- Publication explores structure-activity relationships of a broad range of 2C-X analogs - - Innovative research led to the discovery of CYB210010, a potent and long-acting serotonin 5-HT2.

United statesUnited kingdomErik stangGeoff vartyMike palfreymanKen averyRicha tyagiAlex nivorozhkinMike morganAmy reicheltTina muellerJosh hartselDoug drysdaleClint canalPradip pathareDrug administration

Cybin Inc (CYBN) Reports Publication of Research Manuscript in the Journal of Medicinal Chemistry

Cybin Inc (CYBN) Reports Publication of Research Manuscript in the Journal of Medicinal Chemistry
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesTina muellerAmy reicheltClint canalDoug drysdalePradip pathareJosh hartselMike palfreymanGeoff vartyErik stangAlex nivorozhkinRicha tyagiMike morganKen averyCybin incStructure activity relationships

Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results

Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMichaelg palfreymanAlex kelmanGabriel fahelAaron bartloneAlex belserTina muellerMagdyl shenoudaJoan krakowskyErik stangSebastian krempienMichaele morganKen averyKimball johnsonAlex nivorozhkin

Cybin Announces Poster Presentation at Neuroscience 2023 Annual Meeting

TORONTO, November 15, 2023 Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced a poster presentation at Neuroscience 2023 hosted by the Society for Neuroscience ("SFN") taking place November 11-15, 2022, in Washington, D.C.

United statesUnited kingdomClintone canalMichaele morganPradip pathareRicha tyagiErik stangJoshuaa hartselGabriel fahelGeoff vartyGeoffreyb vartyAmyc reicheltAlex nivorozhkinKen averyTinaa muellerMichaelg palfreyman

Cybin Inc Presents CYB003 Preclinical Data at Neuroscience 2022

15.11.2022 - Cybin Inc. (NEO:CYBN) (NYSE American: CYBN) (Cybin or the Company), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics, today announced that the Company presented a poster highlighting preclinical data for its deuterated . Seite 1

San diegoUnited statesGeoffrey vartyAmy reicheltMichael morganJoshua hartselAlex nivorozhkinClinton canalJoan krakowskyGeoff vartyMichael palfreymanTina muellerPradip pathareKen averyCybin incHead of research development at cybin